Skip to Content
Interactive Textbook on Clinical Symptom Research Logo


Home button

Trial Design: Pain Sections
Author Bio
Introduction
Placebo Effects
Single Dose Trials
Repeated Dose Trials
Explanatory Versus Pragmatic
Dose-Response
Currently selected section: Parallel Group Versus Crossover
Conclusion
 

 

Chapter 1: Clinical Trials of Pain Treatment: Parallel Group Versus Crossover Designs

 
          

Parallel Group Designs

Parallel study designs are preferable when there are strong concerns about carryover effects, or when the natural history of the disorder makes progression likely during the period required for a crossover study. Within-patient variability is the major problem posed by parallel group designs, and several approaches have been suggested to mitigate its impact (Lavori et al., 1983). For example, baseline pain scores may be subtracted from the treatment scores to yield pain intensity difference scores, or they may be treated as a covariate. This often eliminates a large part of the variance, thereby increasing the power of treatment comparisons.

The investigator should also make an effort to balance the treatment groups for variables that predict response, whenever these predictors are known or suspected. If one wishes to examine response in specific subgroups, assignments must also be balanced appropriately. Groups can be balanced using stratification or various techniques of adaptive randomization (Therneau, 1993; Friedman et al., 1996). In studies with sample sizes typical of single center trials, 20-40 patients per group, these methods can significantly increase the power of a study if the prognostic variables are well chosen and the statistical methods take the balancing method into account (Lavori et al., 1983). With sample size above 50 per group, the randomization process alone is likely to balance out most variables (Meinert, 1986). If stratification is not feasible, post hoc covariate analyses or other statistical techniques may be an acceptable substitute if the variables in question are distributed fairly evenly among the treatment groups.

Page 51 of 52
      Previous Page